BB-10010

Known as: BB 10010, BB10010 
 

Topic mentions per year

Topic mentions per year

1995-2003
02419952003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Irradiation of the small intestine can result in depletion of the epithelial stem cell compartment and is often the dose-limiting… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
1999
1999
BACKGROUND The small-intestinal epithelium, a rapidly proliferating tissue, is highly sensitive to cycle-specific agents such as… (More)
Is this relevant?
1999
1999
Chemotherapy-induced neutropenia is a major dose-limiting factor in the management of cancer patients. Most chemotherapeutic… (More)
Is this relevant?
1998
1998
BB-10010 is a variant of the human form of macrophage inflammatory protein-1alpha (MIP-1alpha), which has been shown in mice to… (More)
Is this relevant?
1998
1998
Macrophage Inflammatory Protein (MIP)-1alpha is myelosuppressive in vitro and in vivo for hematopoietic stem and immature subsets… (More)
Is this relevant?
1997
1997
FACS-selected CD34+ HLA-DR- cells (DR- cells) may provide a source of benign stem cells suitable for autografting in chronic… (More)
Is this relevant?
1997
1997
Macrophage inflammatory protein-1alpha (MIP-1alpha) is a chemokine that can inhibit the cell cycle progression of both primitive… (More)
Is this relevant?
1996
1996
Macrophage inflammatory protein-1 alpha (MIP-1 alpha) is an inhibitor of stem cell proliferation affording protection against… (More)
  • table II
  • table I
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1995
1995
BB-10010 is a genetically engineered variant of human macrophage inflammatory protein-1 alpha with improved solution properties… (More)
Is this relevant?
1995
1995
The stem cell inhibitor, macrophage inflammatory protein-1 alpha (MIP-1 alpha) or LD78, protects multipotent hematopoietic… (More)
Is this relevant?